Tocilizumab: The first interleukin-6-receptor inhibitor
Top Cited Papers
- 1 August 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 65 (15), 1413-1418
- https://doi.org/10.2146/ajhp070449
Abstract
Purpose. The pharmacology, pharmacokinetics, clinical efficacy, safety, and role of tocilizumab in rheumatoid arthritis (RA) are reviewed.Keywords
This publication has 36 references indexed in Scilit:
- Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid ArthritisAnnals of Internal Medicine, 2006
- Inflammation: A pivotal link between autoimmune diseases and atherosclerosisAutoimmunity Reviews, 2006
- Fatigue in rheumatoid arthritis reflects pain, not disease activityRheumatology, 2006
- Genetics of Rheumatoid ArthritisMayo Clinic Proceedings, 2006
- The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentArthritis & Rheumatism, 2005
- Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control studyArthritis Research & Therapy, 2005
- Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population‐based cohort studyArthritis & Rheumatism, 2005
- A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexateAnnals Of The Rheumatic Diseases, 2004
- Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid ArthritisNew England Journal of Medicine, 2004
- Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trialThe Lancet, 2004